课题基金 / 基金详情

Molecular pharmacology of Kv channel activators: an emerging class of anti-epileptic drugs.

Kv 通道激活剂的分子药理学：一类新兴的抗癫痫药物。

批准号：

412739

负责人：

Lamothe Shawn M

金额：

$6.56万

依托单位：

University of Alberta

依托单位国家：

加拿大

项目类别：

Fellowship Programs

财政年份：

2019

资助国家：

加拿大

项目状态：

已结题

起止时间：

2019-10-01 至 2021-10-01

来源：

https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=412739&lang=en

关键词：

Abnormal Brain Activity Drug Discovery And Development Epilepsy And Epileptic Seizures Genetic Mutations Ion Channels Neurodevelopmental Delay Neurons Novel Subtypes Of Potassium Channel Activators Potassium Channels Protein Function

项目摘要

项目成果

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

Epilepsy is a nervous system disorder that causes seizures from abnormal brain activity. It is a disease that affects nearly 1% of the population worldwide. Many old drugs are still used to treat epilepsy eventhough several challenges still persist includ

期刊论文(0)

专著(0)

科研奖励(0)

会议论文